HaloPROTAC-E structure
|
Common Name | HaloPROTAC-E | ||
---|---|---|---|---|
CAS Number | 2365478-58-4 | Molecular Weight | 790.41 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C39H56ClN5O8S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of HaloPROTAC-EHaloPROTAC-E is a novel HaloPROTAC potent degrader, inducing reversible degradation of two endosomally localized proteins, SGK3 and VPS34, with a DC50 of 3-10 nM, remarkably selective inducing only degradation of the Halo tagged endogenous VPS34 complex (VPS34, VPS15, Beclin1, and ATG14). |
Name | (2S,4R)-N-(2-(2-(2-(2-((6-Chlorohexyl)oxy)ethoxy)ethoxy)ethoxy)-4-(4-methylthiazol-5-yl)benzyl)-1-((S)-2-(1-cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxamide |
---|---|
Synonym | More Synonyms |
Description | HaloPROTAC-E is a novel HaloPROTAC potent degrader, inducing reversible degradation of two endosomally localized proteins, SGK3 and VPS34, with a DC50 of 3-10 nM, remarkably selective inducing only degradation of the Halo tagged endogenous VPS34 complex (VPS34, VPS15, Beclin1, and ATG14). |
---|---|
Related Catalog | |
References |
Molecular Formula | C39H56ClN5O8S |
---|---|
Molecular Weight | 790.41 |
MFCD32662642 |
HaloPROTAC-E |